{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,23]],"date-time":"2024-03-23T01:07:32Z","timestamp":1711156052080},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,3,22]]},"DOI":"10.7759\/cureus.56708","type":"journal-article","created":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T13:36:36Z","timestamp":1711114596000},"source":"Crossref","is-referenced-by-count":0,"title":["Differentiating Leukostasis From COVID-19 Pneumonia: Clinical and Radiological Perspectives for the Right Decision-Making"],"prefix":"10.7759","author":[{"given":"Nouama","family":"Bouanani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ibtihal","family":"Abouchabaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s13546-013","article-title":"Infiltrations pulmonaires sp\u00e9cifiques \u00e0 la phase initiale des leuc\u00e9mies aigu\u00ebs my\u00e9lo\u00efdes: le poumon leuc\u00e9mique du diagnostic au traitement","volume":"22","author":"Moreau AS","year":"2013","unstructured":"Moreau AS, Vincent F, Azoulay E, et al.. Infiltrations pulmonaires sp\u00e9cifiques \u00e0 la phase initiale des leuc\u00e9mies aigu\u00ebs my\u00e9lo\u00efdes: le poumon leuc\u00e9mique du diagnostic au traitement. R\u00e9animation. 2013, 22:462-9. 10.1007\/s13546-013","journal-title":"R\u00e9animation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0772","article-title":"Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)","volume":"100","author":"Byrd JC","year":"2002","unstructured":"Byrd JC, Mr\u00f3zek K, Dodge RK, et al.. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood. 2002, 100:4325-36. 10.1182\/blood-2002-03-0772","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10357","article-title":"Overview of the pathogenesis and treatment of SARS-CoV-2 for clinicians: a comprehensive literature review","volume":"12","author":"Voto C","year":"2020","unstructured":"Voto C, Berkner P, Brenner C. Overview of the pathogenesis and treatment of SARS-CoV-2 for clinicians: a comprehensive literature review. Cureus. 2020, 12:e10357. 10.7759\/cureus.10357","journal-title":"Cureus"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.virol.2020.08.011","article-title":"The novel coronavirus disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies","volume":"551","author":"Seyed Hosseini E","year":"2020","unstructured":"Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Haddad Kashani H. The novel coronavirus disease-2019 (COVID-19): mechanism of action, detection and recent therapeutic strategies. Virology. 2020, 551:1-9. 10.1016\/j.virol.2020.08.011","journal-title":"Virology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.25259\/JCIS_192_2020","article-title":"CO-RADS: coronavirus classification review","volume":"11","author":"Penha D","year":"2021","unstructured":"Penha D, Pinto EG, Matos F, et al.. CO-RADS: coronavirus classification review. J Clin Imaging Sci. 2021, 11:9. 10.25259\/JCIS_192_2020","journal-title":"J Clin Imaging Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e2476","article-title":"Evaluation of the RSNA and CORADS classifications for COVID-19 on chest computed tomography in the Brazilian population","volume":"76","author":"Fonseca EK","year":"2021","unstructured":"Fonseca EK, Loureiro BM, Strabelli DG, et al.. Evaluation of the RSNA and CORADS classifications for COVID-19 on chest computed tomography in the Brazilian population. Clinics (Sao Paulo). 2021, 76:e2476. 10.6061\/clinics\/2021\/e2476","journal-title":"Clinics (Sao Paulo)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10552-007-9097-2","article-title":"Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002","volume":"19","author":"Yamamoto JF","year":"2008","unstructured":"Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008, 19:379-90. 10.1007\/s10552-007-9097-2","journal-title":"Cancer Causes Control"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2292","article-title":"Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest","volume":"34","author":"Ali AM","year":"2016","unstructured":"Ali AM, Mirrakhimov AE, Abboud CN, Cashen AF. Leukostasis in adult acute hyperleukocytic leukemia: a clinician's digest. Hematol Oncol. 2016, 34:69-78. 10.1002\/hon.2292","journal-title":"Hematol Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1095154","article-title":"Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms","volume":"13","author":"Ghiaur A","year":"2023","unstructured":"Ghiaur A, Doran C, Ionescu B, et al.. Case report: High-risk acute promyelocytic leukemia and COVID-19-related myocarditis one patient, two cytokine storms. Front Oncol. 2023, 13:1095154. 10.3389\/fonc.2023.1095154","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/postgradmedj-2020-138234","article-title":"Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19)","volume":"96","author":"Umakanthan S","year":"2020","unstructured":"Umakanthan S, Sahu P, Ranade AV, et al.. Origin, transmission, diagnosis and management of coronavirus disease 2019 (COVID-19). Postgrad Med J. 2020, 96:753-8. 10.1136\/postgradmedj-2020-138234","journal-title":"Postgrad Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102310","article-title":"Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments?","volume":"9","author":"Bewersdorf JP","year":"2020","unstructured":"Bewersdorf JP, Zeidan AM. Hyperleukocytosis and leukostasis in acute myeloid leukemia: can a better understanding of the underlying molecular pathophysiology lead to novel treatments?. Cells. 2020, 9:2310. 10.3390\/cells9102310","journal-title":"Cells"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2012.01.003","article-title":"Hyperleukocytosis, leukostasis and leukapheresis: practice management","volume":"26","author":"Ganzel C","year":"2012","unstructured":"Ganzel C, Becker J, Mintz PD, Lazarus HM, Rowe JM. Hyperleukocytosis, leukostasis and leukapheresis: practice management. Blood Rev. 2012, 26:117-22. 10.1016\/j.blre.2012.01.003","journal-title":"Blood Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-976170","article-title":"Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome","volume":"33","author":"Blum W","year":"2007","unstructured":"Blum W, Porcu P. Therapeutic apheresis in hyperleukocytosis and hyperviscosity syndrome. Semin Thromb Hemost. 2007, 33:350-4. 10.1055\/s-2007-976170","journal-title":"Semin Thromb Hemost"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-551507","article-title":"How I treat hyperleukocytosis in acute myeloid leukemia","volume":"125","author":"R\u00f6llig C","year":"2015","unstructured":"R\u00f6llig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia. Blood. 2015, 125:3246-52. 10.1182\/blood-2014-10-551507","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/205664-differentiating-leukostasis-from-covid-19-pneumonia-clinical-and-radiological-perspectives-for-the-right-decision-making","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T13:36:41Z","timestamp":1711114601000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/205664-differentiating-leukostasis-from-covid-19-pneumonia-clinical-and-radiological-perspectives-for-the-right-decision-making"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.56708","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,22]]}}}